IL15 and hepatocellular carcinoma: Subjects with plasmatic IL-15 ≥ 12.40 pg/mL and IL-5 in ascites ≥ 15.86 pg/mL were classified as patients without HCC (node 5, 17 patients), whereas those with IL-5 < 15.86 pg/mL were identified as HCC patients (node 4, 8 patients).